Acalabrutinib (ACP-196): A Covalent Bruton Tyrosine Kinase Inhibitor with a Differentiated Selectivity and In Vivo Potency Profile.
J Pharmacol Exp Ther
; 363(2): 240-252, 2017 11.
Article
in En
| MEDLINE
| ID: mdl-28882879
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyrazines
/
Benzamides
/
Protein-Tyrosine Kinases
/
Protein Kinase Inhibitors
Limits:
Animals
/
Humans
Language:
En
Journal:
J Pharmacol Exp Ther
Year:
2017
Type:
Article
Affiliation country:
Netherlands